The Role of Antibiotics After Surgical Treatment of Simple Hand Infections: A Prospective Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Theodora Manoli, BG Trauma Center Tuebingen
ClinicalTrials.gov Identifier:
NCT01429571
First received: September 1, 2011
Last updated: September 6, 2011
Last verified: September 2011
  Purpose

Three patient groups with simple hand infections are tested regarding the necessity of antibiotics after surgical treatment.


Condition Intervention
Hand Infections
Other: No intervention

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by BG Trauma Center Tuebingen:

Enrollment: 90
Study Start Date: August 2009
Study Completion Date: December 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Systemic and local antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.
Local antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.
No antibiotics Other: No intervention
No intervention
Other Name: Since our study was observational after the beginning of treatment with or without antibiotics no intervention was influenced by the study.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Adult patients with simple hand infections (no infection of the bone, tendon or joint)

Criteria

Inclusion Criteria:

  • Adult patients with simple hand infections

Exclusion Criteria:

  • Infection of the bone, tendon or joint
  • Major diseases like diabetes or immunodeficiency
  • Systemic manifestations like fever or lymphangitis
  • Bite infections
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01429571

Locations
Germany
BG Trauma Center
Tuebingen, Germany, 72076
Sponsors and Collaborators
BG Trauma Center Tuebingen
  More Information

No publications provided

Responsible Party: Dr. Theodora Manoli, MD, BG Trauma Center Tuebingen
ClinicalTrials.gov Identifier: NCT01429571     History of Changes
Other Study ID Numbers: Antibiotics in hand infections
Study First Received: September 1, 2011
Last Updated: September 6, 2011
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antitubercular Agents

ClinicalTrials.gov processed this record on September 14, 2014